Tolerance and Pharmacokinetic Interactions of Rifabutin and Clarithromycin in Human Immunodeficiency Virus-Infected Volunteers

This study evaluated the tolerance and potential pharmacokinetic interactions between clarithromycin (500 mg every 12 h) and rifabutin (300 mg daily) in clinically stable human immunodeficiency virus-infected volunteers with CD4 counts of <200 cells/mm(3). Thirty-four subjects were randomized equ...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Hafner, Richard, Bethel, James, Power, Maureen, Landry, Bernard, Banach, Mary, Mole, Larry, Standiford, Harold C., Follansbee, Stephen, Kumar, Princy, Raasch, Ralph, Cohn, David, Mushatt, David, Drusano, George
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 1998
Konular:
Pharmacology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC105510/
https://ncbi.nlm.nih.gov/pubmed/9517944
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller